High-value nutritional solutions manufacturer Clover Corporation (ASX: CLV) has reported a turnaround in performance for FY2025, underpinned by expansion in Europe and Asia across the nutraceutical, food & beverage, and infant formula sectors. The company recorded a 38% boost in revenue to $48.4 million from $37.6m in the previous corresponding period, while net sales revenue increased to $86m from $62.2m. Net profit after tax hit $7m (compared to the previous year’s $1.5 million), driven by new customers and higher order volumes from existing clients. Crude tuna oil extraction delivered strong yield and quality year-round, providing a secure and cost-effective supply of critical raw materials in a tight market. Clover has appointed dedicated distributors across key markets to manage marketing, inventory, and warehousing.